Search Results - "Shema, Kristen"
-
1
Tunable Blood Shunt for Neonates With Complex Congenital Heart Defects
Published in Frontiers in bioengineering and biotechnology (13-01-2022)“…Despite advancements in procedures and patient care, mortality rates for neonatal recipients of the Norwood procedure, a palliation for single ventricle…”
Get full text
Journal Article -
2
Abstract 2892: Development of claudin 6 bispecific antibodies for treatment of ovarian cancer
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract There is growing interest in applying antibody modalities including bispecifics, antibody-drug conjugates, and CART to solid tumors. However,…”
Get full text
Journal Article -
3
Abstract 1865: Development of CTIM-76, a highly specific Claudin 6 bispecific antibody for treatment of ovarian cancer
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…Abstract Solid tumors lead to 580,000 deaths annually in the US, and safe and effective therapeutics for many late-stage solid tumors are lacking. Ovarian…”
Get full text
Journal Article -
4
Antibody specificity against highly conserved membrane protein Claudin 6 driven by single atomic contact point
Published in iScience (22-12-2022)“…The tight junction protein claudin 6 (CLDN6) is differentially expressed on cancer cells with almost no expression in healthy tissue. However, achieving…”
Get full text
Journal Article -
5
Abstract 318: Atomic-level specificity of Claudin 6 monoclonal antibodies isolated for treating solid tumors
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract The tight junction protein Claudin 6 (CLDN6) is differentially expressed on cancer cells with almost no expression in healthy tissue, making it a…”
Get full text
Journal Article -
6
Abstract 317: Isolation of highly selective antibodies against claudin 18.2 for the treatment of solid tumors
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract Monoclonal antibodies (MAbs) are a well-established treatment approach in oncology and other diseases. Nevertheless, many multipass membrane proteins…”
Get full text
Journal Article -
7
Abstract 6305: Bispecific claudin 18.2 and GPRC5D antibodies with potent cell-killing activity for cancer therapeutics
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…Abstract Tumor-associated antigens with little or no expression in healthy tissue are attractive targets for anti-tumor modalities including T cell-engaging…”
Get full text
Journal Article -
8
Abstract 1543: Discovery of CCR8 antibodies targeting regulatory T cells to enable tumor sensitization
Published in Cancer research (Chicago, Ill.) (04-04-2023)“…Abstract Regulatory T (Treg) cells in the tumor microenvironment have an immune suppressive function, and their presence is associated with poor prognosis…”
Get full text
Journal Article